Are psychedelics the new medical marijuana?
“The major benefit seems to be that there’s an improved equilibrium of systems throughout the body, which is why it seems to affect so many different systems,” he said… but for addicts, vets, and people suffering from disorders who could find help in these drugs, the stakes are as high as their very survival.
LSD and Ibogaine are not the only psychedelics making a comeback and seeking legitimacy in science and health. Magic mushrooms, MDMA, Ayahuasca, and psilocybin, among others, are being studied for their potential benefits to treat a number of illnesses and mental disorders. “We found that (MDMA) almost doubled the effectiveness of the treatment,” said Allison Feduccia, a researcher at MAPS. “People who were in the MDMA group had significant reductions in their PTSD symptoms two months after completing of the sessions and then also we followed up with them 12 months later and found that 67 percent of participants at that point no longer met criteria for PTSD.” MAPS enrolled 107 subjects across six different study sites in the U.S., Canada and Israel, treating different kinds of PTSD. One study specifically enrolled veterans firefighters and police officers. “It’s really a long-term durable effect that we see with this treatment is quite promising,” said Feduccia. “This is a very difficult condition to treat with the current medications and therapy available.”